- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics Inc stock price live, this page displays NASDAQ VVOS stock exchange data. View the VVOS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vivos Therapeutics Inc real time stock price chart below.
What Is the Vivos Therapeutics Inc Stock Price Today?
The Vivos Therapeutics Inc stock price today is 4.4600.
What Is the Stock Symbol for Vivos Therapeutics Inc?
The stock symbol for Vivos Therapeutics Inc is ""VVOS.""
What Stock Exchange Does Vivos Therapeutics Inc Trade On?
Vivos Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Vivos Therapeutics Inc a Good Stock to Buy?
Determining whether Vivos Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VVOS quote. (ISIN: US92859E2072)
What Is the Vivos Therapeutics Inc Stock Price Today?
The Vivos Therapeutics Inc stock price today is 4.4600.
What Is the Stock Symbol for Vivos Therapeutics Inc?
The stock symbol for Vivos Therapeutics Inc is ""VVOS.""
What Stock Exchange Does Vivos Therapeutics Inc Trade On?
Vivos Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Vivos Therapeutics Inc a Good Stock to Buy?
Determining whether Vivos Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VVOS quote. (ISIN: US92859E2072)
NASDAQ
Currency in USD
4.4600
-0.2650(-5.61%)
Closed·
After Hours
4.7000+0.2400(+5.38%)
·
Fair Value
An estimate of a Vivos's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.3987
4.8800
52 wk Range
1.9700
7.9500
VVOS Scorecard
Full Analysis
Quickly burning through cash
Unusual Post-Market activity
Fair Value
An estimate of a Vivos's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.39874.8800
52 wk Range
1.97007.9500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VVOS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vivos's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
4.2250
Downside
-5.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Vivos Therapeutics Inc Company Profile
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Vivos Therapeutics Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue fell to $3M from $3.4M in Q1 2024; product sales rose 8% to $1.8M; stock up 2.94% after-hours to $3.15
- Gross profit down to $1.5M from $1.9M; operating loss increased slightly to $3.9M; cash reserves decreased to $2.3M
- Company focusing on strategic acquisitions; Sleep Center of Nevada acquisition expected to be accretive in Q3 2025
- FDA clearance obtained for treating severe Obstructive Sleep Apnea in adults; pivoting strategy towards sleep medicine market
- Revenue growth forecast at 15% for FY2025; aiming for cash flow positive status in near term despite current financial constraints
Last Updated: 15/05/2025, 22:56
Read Full TranscriptCompare VVOS to Peers and Sector
Metrics to compare | VVOS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVVOSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −1.6x | −0.5x | |
PEG Ratio | −0.03 | 0.01 | 0.00 | |
Price/Book | 6.0x | 1.9x | 2.6x | |
Price / LTM Sales | 1.8x | 0.8x | 3.2x | |
Upside (Analyst Target) | −6.1% | 43.6% | 42.0% | |
Fair Value Upside | Unlock | 24.9% | 6.6% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.2250
(-5.27% Downside)
Earnings
Latest Release
May 16, 2025
EPS / Forecast
-0.45 / -0.41
Revenue / Forecast
3.02M / 4.10M
People Also Watch
FAQ
What Stock Exchange Does Vivos Trade On?
Vivos is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Vivos?
The stock symbol for Vivos is "VVOS."
What Is the Vivos Market Cap?
As of today, Vivos market cap is 26.21M.
What Is Vivos's Earnings Per Share (TTM)?
The Vivos EPS (TTM) is -1.70.
When Is the Next Vivos Earnings Date?
Vivos will release its next earnings report on 12 Aug 2025.
From a Technical Analysis Perspective, Is VVOS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Vivos Stock Split?
Vivos has split 1 times.
How Many Employees Does Vivos Have?
Vivos has 113 employees.
What is the current trading status of Vivos (VVOS)?
As of 30 Jul 2025, Vivos (VVOS) is trading at a price of 4.46, with a previous close of 4.73. The stock has fluctuated within a day range of 4.40 to 4.88, while its 52-week range spans from 1.97 to 7.95.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.